Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2054 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  My preferences 


This article has been cited by
1Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Michal Wicinski,Bartlomiej J. Kaluzny,Slawomir Liberski,Daria Marczak,Malgorzata Seredyka-Burduk,Katarzyna Pawlak-Osinska
Survey of Ophthalmology.2019;64(2)185
2Pharmacokinetic considerations for current state-of-the-art antidepressants
Elzbieta Wyska
Expert Opinion on Drug Metabolism & Toxicology.2019;15(10)831
3Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder
David J. Hellerstein,Jonathan W. Stewart,Ying Chen,Vinushini Arunagiri,Bradley S. Peterson,Patrick J. McGrath
Journal of Affective Disorders.2019;245(10)403
4Transdermal Route: A Viable Option for Systemic Delivery of Antidepressants
Akeemat O. Tijani,Estefany Nunez,Karyn Singh,Garima Khanna,Ashana Puri
Journal of Pharmaceutical Sciences.2021;110(9)3129